Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.30 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24382201 | 0.93 | KDM4E (0.32) | L3MBTL1TDP1NPC1RAB9AAHR | |
| SCHEMBL23738421 | 0.92 | AHR (0.33) | NPC1RAB9AAHRMEN1MAPT | |
| SCHEMBL25051306 | 0.91 | TUBB4A (0.31) | AHRMAPT | |
| SCHEMBL25051104 | 0.90 | — | — | |
| SCHEMBL25049059 | 0.90 | MAPT (0.34) | L3MBTL1NPC1RAB9AAHRMEN1 | |
| SCHEMBL25050964 | 0.89 | L3MBTL1 (0.32) | L3MBTL1TDP1NPC1RAB9AAHR | |
| SCHEMBL23737330 | 0.89 | AHR (0.31) | AHR | |
| SCHEMBL25051761 | 0.89 | AHR (0.32) | NPC1AHRMAPT | |
| SCHEMBL23737157 | 0.88 | CHEK2 (0.31) | — | |
| SCHEMBL23737935 | 0.88 | ABCG2 (0.36) | L3MBTL1TDP1NPC1RAB9AAHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230049674-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-02-16 | — | — | US | disclosed |
| EP-3863077-B1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2022-05-04 | — | — | EP | disclosed |
| EP-3863077-A1 | ORGANIC LIGHT EMITTING DIODE | LG Chem, Ltd. (KR) | 2021-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230049674-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY2, ELOVL1, CRY1 | L3MBTL1 213/4885TDP1 1508/4885NPC1 3805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.